date:Oct 13, 2012
uit, and the FDA declined to comment on the specific litigation. The U.S. Department of Justice hasn't filed an answer yet in the case, which is scheduled for a status conference with the judge on Nov. 7, Tomaselli said.
In general I can say that publishing the FSMA rules is a priority for the agency, FDA Spokeswoman Carla Daniels said in emailed comments. While the rule-making process can be complex and demanding, it will eventually provide for a framework that will have an enormous impact in